Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Manfrid Eltze
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Anatomy
Chemicals & Drugs
Phenomena
Concepts & Ideas
Procedures
Sign-in to see full Profile
Network (preview)
7
Schudt, Christian
6
Ullrich, Brigitte
6
Grebe, Thomas
4
Lambrecht, Günter
4
Mutschler, Ernst
3
Strub, Andreas
3
Ulrich, Wolf-Rüdiger
3
König, H
3
Boer, Rainer
2
Barsig, Johannes
2
Michel, Martin
2
Lehner, Martin
2
Hatzelmann, Armin
1
Illes, Peter
1
Jackisch, Rolf
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Manfrid Eltze (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Stoll Christoph; Eltze Manfrid; Lambrecht Günter; Zentner Josef; Feuerstein Thomas J; Jackisch Rolf
Functional characterization of muscarinic autoreceptors in rat and human neocortex.
Journal of neurochemistry 2009;110(3):837-47.
-
2007: Klein Thomas; Eltze Manfrid; Grebe Thomas; Hatzelmann Armin; Kömhoff Martin
Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.
Cardiovascular research 2007;75(2):390-7.
-
2007: Hamacher Jürg; Eichert Katja; Braun Clemens; Grebe Thomas; Strub Andreas; Lucas Rudolf; Eltze Manfrid; Wendel Albrecht
Montelukast exerts no acute direct effect on NO synthases.
Pulmonary pharmacology & therapeutics 2007;20(5):525-33.
-
2006: Lehner Martin D; Marx Degenhard; Boer Rainer; Strub Andreas; Hesslinger Christian; Eltze Manfrid; Ulrich Wolf-Rüdiger; Schwoebel Frank; Schermuly Ralph Theo; Barsig Johannes
In vivo characterization of the novel imidazopyridine BYK191023 [2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine], a potent and highly selective inhibitor of inducible nitric-oxide synthase.
The Journal of pharmacology and experimental therapeutics 2006;317(1):181-7.
-
2006: Strub Andreas; Ulrich Wolf-Rüdiger; Hesslinger Christian; Eltze Manfrid; Fuchss Thomas; Strassner Jochen; Strand Susanne; Lehner Martin D; Boer Rainer
The novel imidazopyridine 2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) is a highly selective inhibitor of the inducible nitric-oxide synthase.
Molecular pharmacology 2006;69(1):328-37.
-
2004: Jähnichen Sven; Eltze Manfrid; Pertz Heinz H
Evidence that alpha(1B)-adrenoceptors are involved in noradrenaline-induced contractions of rat tail artery.
European journal of pharmacology 2004;488(1-3):157-67.
-
2002: Eltze Manfrid; Grebe Thomas; Michel Martin C; Czyborra Peter; Ullrich Brigitte
Affinity profile at alpha(1)- and alpha(2)-adrenoceptor subtypes and in vitro cardiovascular actions of (+)-boldine.
European journal of pharmacology 2002;443(1-3):151-68.
-
2001: Eltze M; Boer R; Michel M C; Hein P; Testa R; Ulrich W R; Kolassa N; Sanders K H
In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic alpha1A- vs. alpha1B- and alpha1D-adrenoceptors.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(6):649-62.
-
2001: Bundschuh D S; Eltze M; Barsig J; Wollin L; Hatzelmann A; Beume R
In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor.
The Journal of pharmacology and experimental therapeutics 2001;297(1):280-90.
-
2001: Eltze M; König H; Ullrich B; Grebe T
Failure of AH11110A to functionally discriminate between alpha(1)-adrenoceptor subtypes A, B and D or between alpha(1)- and alpha(2)-adrenoceptors.
European journal of pharmacology 2001;415(2-3):265-76.
-
1999: Eltze M; König H; Ullrich B; Grebe T
Buspirone functionally discriminates tissues endowed with alpha1-adrenoceptor subtypes A, B, D and L.
European journal of pharmacology 1999;378(1):69-83.
-
1997: Eltze M; König H; Ullrich B; Grebe T
Contraction of guinea-pig gallbladder: muscarinic M3 or M4 receptors?
European journal of pharmacology 1997;332(1):77-87.
-
1996: Eltze M
Functional evidence for an alpha 1B-adrenoceptor mediating contraction of the mouse spleen.
European journal of pharmacology 1996;311(2-3):187-98.
-
1996: Eltze M; Ullrich B
Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney.
European journal of pharmacology 1996;306(1-3):139-52.
-
1996: Eltze M
In functional experiments, risperidone is selective, not for the B, but for the A subtype of alpha 1-adrenoceptors.
European journal of pharmacology 1996;295(1):69-73.
-
1994: Eltze M
Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens.
European journal of pharmacology 1994;263(1-2):31-7.
-
1994: Eltze M
Characterization of the alpha 1-adrenoceptor subtype mediating contraction of guinea-pig spleen.
European journal of pharmacology 1994;260(2-3):211-20.
-
1994: Eltze M; Galvan M
Involvement of muscarinic M2 and M3, but not of M1 and M4 receptors in vagally stimulated contractions of rabbit bronchus/trachea.
Pulmonary pharmacology 1994;7(2):109-20.
-
1993: Eltze M; Ullrich B; Mutschler E; Moser U; Bungardt E; Friebe T; Gubitz C; Tacke R; Lambrecht G
Characterization of muscarinic receptors mediating vasodilation in rat perfused kidney.
European journal of pharmacology 1993;238(2-3):343-55.
-
1992: Eltze M; Boer R
The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
European journal of pharmacology 1992;224(2-3):125-36.
-
1992: Bott A; Eltze M; Illes P
External ATP antagonizes the effect of potassium channel openers in guinea-pig ventricular papillary muscle.
European journal of pharmacology 1992;213(1):141-4.
-
1992: Eltze M; Mutschler E; Lambrecht G
Affinity profiles of pizotifen, ketotifen and other tricyclic antimuscarinics at muscarinic receptor subtypes M1, M2 and M3.
European journal of pharmacology 1992;211(3):283-93.
-
1991: Kromer W; Eltze M
Is field (vagal) stimulation of gastric acid secretion mediated by M1 or non-M1 muscarinic receptors? A methodical problem exemplified in the mouse stomach in vitro.
Journal of autonomic pharmacology 1991;11(5):337-42.
-
1991: Eltze M; Boer R; Sanders K H; Kolassa N
Vasodilatation elicited by 5-HT1A receptor agonists in constant-pressure-perfused rat kidney is mediated by blockade of alpha 1A-adrenoceptors.
European journal of pharmacology 1991;202(1):33-44.
-
1991: Kromer W; Baron E; Boer R; Eltze M
Telenzepine inhibits electrically-stimulated, acetylcholine plus histamine-mediated acid secretion in the mouse isolated stomach by blockade of M1 muscarine receptors.
Naunyn-Schmiedeberg's archives of pharmacology 1991;343(1):7-13.
-
1991: Kilian U; Beume R; Eltze M; Häfner D; Hanauer G; Schudt C
Telenzepine and its enantiomers, M1-selective antimuscarinics, in guinea pig lung function tests.
Agents and actions. Supplements 1991;34():131-47.
-
1991: Schudt C; Winder S; Eltze M; Kilian U; Beume R
Zardaverine: a cyclic AMP specific PDE III/IV inhibitor.
Agents and actions. Supplements 1991;34():379-402.
-
1990: Eltze M
Telenzepine enantiomers block muscarinic M1-receptors with opposite kinetics.
European journal of pharmacology 1990;180(1):161-8.
-
1990: Kromer W; Baron E; Beinborn M; Boer R; Eltze M
Characterization of the muscarine receptor type on paracrine cells activated by McN-A-343 in the mouse isolated stomach.
Naunyn-Schmiedeberg's archives of pharmacology 1990;341(3):165-70.
-
1990: Eltze M; Boer R; Sanders K H; Boss H; Ulrich W R; Flockerzi D
Stereoselective inhibition of thromboxane-induced coronary vasoconstriction by 1,4-dihydropyridine calcium channel antagonists.
Chirality 1990;2(4):233-40.
-
1989: Eltze M; Lambrecht G; Mutschler E
Cyproheptadine displays high affinity for muscarinic receptors but does not discriminate between receptor subtypes.
European journal of pharmacology 1989;173(2-3):219-22.
-
1989: Eltze M; Boer R; Mutschler E; Lambrecht G
Affinity profiles of BTM-1086 and BTM-1041 at muscarinic receptor subtypes and at H1- and alpha 1-receptors.
European journal of pharmacology 1989;170(3):225-34.
-
1989: Kromer W; Baron E; Beinborn M; Eltze M; Simon W A
Stimulation by McN-A-343 and blockade by telenzepine of acid secretion in the mouse isolated stomach at histamine-liberating cells.
Naunyn-Schmiedeberg's archives of pharmacology 1989;340(1):68-75.
-
1989: Eltze M
Glibenclamide is a competitive antagonist of cromakalim, pinacidil and RP 49356 in guinea-pig pulmonary artery.
European journal of pharmacology 1989;165(2-3):231-9.
-
1989: Schudt C; Boer R; Eltze M; Riedel R; Grundler G; Birdsall N J
The affinity, selectivity and biological activity of telenzepine enantiomers.
European journal of pharmacology 1989;165(1):87-96.
-
1989: Eltze M
Competitive antagonism by glibenclamide of cromakalim inhibition of twitch contractions in rabbit vas deferens.
European journal of pharmacology 1989;161(1):103-6.
-
1989: Kilian U; Beume R; Eltze M; Schudt C
Is phosphodiesterase inhibition a relevant bronchospasmolytic principle?
Agents and actions. Supplements 1989;28():331-48.
-
1988: Eltze M; Figala V
Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes.
European journal of pharmacology 1988;158(1-2):11-9.
-
1988: Riedel R; Bohnenkamp W; Eltze M; Heintze K; Prinz W; Kromer W
Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat.
Digestion 1988;40(1):25-32.
-
1987: Bohnenkamp W; Eltze M; Heintze K; Kromer W; Riedel R; Schudt C
Specificity of the substituted benzimidazole B 823-08: a prodrug for gastric proton pump inhibition.
Pharmacology 1987;34(5):269-78.
-
1987: Kilian U; Eltze M; Kolassa N
Interaction with histamine H1-receptors and bronchospasmolytic effects of urapidil.
Respiration; international review of thoracic diseases 1987;51(1):16-25.
-
1986: Beil W; Eltze M; Heintze K; Klemm K; Riedel R; Schudt C; Sewing K F; Simon A
The sulphoxide moiety of substituted benzimidazoles is essential for inhibition of parietal cell K+/H+-ATPase.
British journal of pharmacology 1986;88(2):389-95.
-
1985: Eltze M; Gönne S; Riedel R; Schlotke B; Schudt C; Simon W A
Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.
European journal of pharmacology 1985;112(2):211-24.
-
1984: Zech K; Eltze M; Kilian U; Sanders K H; Kolassa N
Biotransformation of urapidil: metabolites in serum and urine and their biological activity in vitro and in vivo.
Archives internationales de pharmacodynamie et de thérapie 1984;272(2):180-96.
-
1983: Baccouche M; Dittmann E C; Eltze M; Kilian U
[Pharmacology of ethylenediamine and its interaction with theophylline]
Praxis und Klinik der Pneumologie 1983;37(8):322-5.
Sign-in to see more
